Luiz Henrique Gebrim
Overview
Explore the profile of Luiz Henrique Gebrim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Micali E, Mattar A, Burattini A, Gebrim L, Vieira R
Indian J Plast Surg
. 2025 Mar;
58(1):70-72.
PMID: 40078844
Locally advanced breast cancer (LABC) is common in countries where organized screening is not effective. Although neoadjuvant therapy increases resectability, many patients undergo mastectomy and, in some cases, flaps are...
2.
Antonini M, Mattar A, Pereira da Costa Pinheiro D, Maia I, Teixeira M, Amorim A, et al.
Breast
. 2025 Feb;
80:104417.
PMID: 39983435
Background: Trastuzumab has significantly improved the treatment of HER2-positive breast cancer, particularly in the neoadjuvant setting, where its combination with chemotherapy increases the pathologic complete response (pCR) rate. This retrospective...
3.
Richter F, Mattar A, Antonini M, Teixeira M, Amorim A, Millen E, et al.
Sci Rep
. 2025 Feb;
15(1):6174.
PMID: 39979484
Body mass index (BMI) is a key factor in the progression of breast cancer (BC), with conflicting evidence on its influence on pathological complete response (pCR) following neoadjuvant chemotherapy (NAC)....
4.
Mattar A, Antonini M, Amorim A, Teixeira M, de Resende C, Cavalcante F, et al.
JCO Glob Oncol
. 2025 Feb;
11:e2400340.
PMID: 39977709
Purpose: Triple-negative breast cancer (TNBC) presents notable treatment difficulties, especially in the public health care systems of low- and middle-income countries where access to advanced therapies is restricted. This study...
5.
Antonini M, Mattar A, Pereira da Costa Pinheiro D, Teixeira M, Amorim A, Ferraro O, et al.
Cancer Control
. 2024 Nov;
31:10732748241303425.
PMID: 39569512
Objectives: The objective of this study was to assess the impact of the COVID-19 pandemic, after 2 years, on mammographic screening in Brazil evaluating BIRADS® results, breast cancer diagnosis rates,...
6.
Antonini M, Mattar A, Richter F, Pannain G, Teixeira M, Amorim A, et al.
Chin Clin Oncol
. 2024 Oct;
13(5):65.
PMID: 39390916
Background: Neoadjuvant chemotherapy (NAC), traditionally used for locally advanced disease, is now applied for operable disease, particularly to treat aggressive breast cancer (BC). This study aimed to characterize the pathological...
7.
Antonini M, Mattar A, Pannain G, Buttenbender S, Pereira da Costa Pinheiro D, Teixeira M, et al.
Heliyon
. 2024 Oct;
10(18):e38183.
PMID: 39364238
Male breast cancer (MBC) is a rare condition, accounting for approximately 1 % of all breast cancer cases. Nevertheless, the paucity of MBC-specific research has impeded a thorough understanding of...
8.
Santana M, Sawada M, Junior D, Giacaglia M, Reis M, Xavier J, et al.
Cells
. 2024 Aug;
13(16.
PMID: 39195217
The association between high-density lipoprotein (HDL) cholesterol and breast cancer (BC) remains controversial due to the high complexity of the HDL particle and its functionality. The HDL proteome was determined...
9.
Antonini M, Mattar A, Richter F, Pannain G, Teixeira M, Amorim A, et al.
Breast
. 2023 Sep;
72:103577.
PMID: 37722319
Objectives: We aimed to evaluate the pCR rate in patients receiving NAC for the treatment of breast cancer (BC) in a multicenter cohort in Brazil. Additionally, we aimed to use...
10.
Santana M, Sawada M, Santos A, Reis M, Xavier J, Correa-Giannella M, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628945
The expression of inflammation-related miRs bound to high-density lipoproteins (HDLs), the anti-inflammatory activity of HDLs isolated from individuals with breast cancer, and controls were determined. Forty newly diagnosed women with...